It’s no surprise that Q318 US revenue growth accelerated YoY when, for the same period last year, the US Total Joints Market experienced major market disruption from two major hurricanes which delayed procedures beyond the usual Q3 procedural slowdown. Industry analysts, including Cantor Fitzgerald’s Craig Bijou, report that US recon growth was relatively flat on a stacked two-year basis. From this perspective, SmartTRAK believes this trend confirms the market is not showing major signs of improvement or decline...

Among the many topics covered in detail in the Q318 Total Joints Market Recap are:

Products that prevent peripheral IV failures could be the next big thing in the market for vascular access adjunct products, a market opportunity valued at more than $600MM in the US alone, according to SmartTRAK estimates.

All eyes were on the high failure rate of peripheral IVs at the Association of Vascular Access (AVA) 2018 Annual Scientific Meeting, with speakers highlighting the 2015 article by Helm et al. “Accepted but Unacceptable: Peripheral IV Catheter Failure,” which estimates a PIV failure rate of 35% to 50% primarily caused by phlebitis, infiltration, occlusion/mechanical failure, dislodgment and infection. Failure is defined as the removal of the catheter prior to the end of its intended life or before the 72 to 96 hours previously used as a guideline. And with up to 90% of all hospitalized patients receiving a PIV, it is a standard but often overlooked procedure in the hospital.

The primary emphasis over the last 10 to 15 years has been the reduction of catheter-related bloodstream infections (CRBSIs) associated with central line catheters. Driving this focus has been CMS reimbursement penalties for hospital acquired central line bloodstream infections (CLABSIs). This new focus on PIVs could be exciting for manufacturers, especially those with adjunct vascular access products. Clinicians insert approximately 250 million PIVs every year in the US (assuming a 25% failure rate on first insertion), a market that is 25 times larger than the US market for central line catheters...

SmartTRAK is excited to be attending OSET - the 2018 Orthopaedic Summit- on December 5-8 at the Bellagio in Las Vegas, Nevada.

Kristina Meyer, Senior Analyst, Sports Medicine will be representing BioMedGPS SmartTRAK at the conference.

During the conference, we are inviting a select few attendees to take part in a complimentary, private “Ask the Analyst” session with our Sports Medicine Expert, Kristina Meyer at the SmartTRAK Booth,  # 326, at OSET.

What can you talk to Kristina about? Here’s what others have asked in the past:

SmartTRAK is so proud of its very latest cutting edge module, Computer-Assisted Surgery, both Spine and Ortho Segments. Elise Wolf, the creator of our Computer-Assisted Surgery Module, launched both in online webinars, the videos which are available to view now! 

Elise Wolf, our Sr. Analyst for Computer Assisted Surgery, led both the webinars and has over 14 years of industry experience in roles including product development, marketing and business development consulting in robotics, emerging medical device technologies and orthopedics.

Please enjoy these overview videos of both modules.

Don't forget! BioMedGPS recently expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of the US Computer Assisted Surgery (CAS) – Ortho module on Tuesday, November 13th.

• Computer Assisted Surgery - Ortho – Tues, Nov. 13 - Register at www.smarttrak.com/cas-ortho

The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.

The new module covers:

• Robotics
• Navigation and surgical planning systems
• Augmented reality technologies 
• Artificial intelligence

The SmartTRAK Robotic and Computer Assisted Surgery module will be managed by Elise Wolf,  a biomedical engineer that worked at a startup out of Carnegie Mellon University on robotic technologies early in her career.

Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at the conference. 

Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL

Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)

To receive a downloadable transcript, click the button below...

The Hemostats and Sealants Market continues to grow at a steady clip. SmartTRAK projects this market will reach more than $3.5B by 2022E with a five-year CAGR of ~5%.

It’s good news for many, but do you know the real story behind those numbers?

SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market. In this Market Outlook article, Doug Devens, SmartTRAK's Senior Analyst, Biosurgery, does a deep dive, discussing what’s fueling this growth and reviews the top market trends you need to know for the year ahead.

• Trend #1: Expanding Indications Fuel Increased Adoption of Fibrin Sealants
• Trend #2: Increasing Use of Sealant Patch Products
• Trend #3: New Plant-Based Technologies Gaining Ground
• Trend #4: Biologic Sealants Ready for Bounce Back

DownloadMarket Outlook: Top Trends to Watch in Hemostats and Sealants

Robotics and other biological technologies created a buzz on the exhibit floor

Elise Wolf, Senior Analyst, Computer-Assisted Surgery, who manages the new Robotics and Computer-Assisted Surgery modules at SmartTRAK, reports on the new technologies in CAS that were being discussed at NASS 2018.

Robotics, navigation and other enabling technologies were hot topics at the North American Spine Society’s (NASS) 33rd annual meeting, held September 25-28, 2018 in Los Angeles, CA. Manufacturers are developing a variety of computer-assisted surgery (CAS) technologies for spine surgery, including surgical planning systems, navigation systems, robotics, augmented reality (AR) technology and artificial intelligence (AI). While growth in the fusion market has slowed over the past few years due to pricing pressure, reduced procedure volumes and reimbursement non-coverage, robotic and other CAS technologies have offered means for growth. With benefits that include more precise implant placement, reduced radiation exposure, decreased invasiveness of procedures and implant pull-through for manufacturers, CAS technologies are gaining traction.
 
Robotics
Robotics was a large topic of discussion during the meeting and on the exhibit floor. Spine market leader Medtronic (MDT) believes strongly in the future of robotics for spine surgery. At the Company’s recent investor conference, MDT executives estimated that up to 35% of instrumented spine procedures will be performed using robotics in 10 years. MDT believes its recent acquisition of Mazor (announced in September) will accelerate its product development and commercialization initiatives in robotics, and positions the Company to capture additional market share in both robotics revenues and core spine through implant pull-through. MDT management noted they are seeing high single-digit implant growth in accounts with capital equipment purchases of Mazor X, and double-digit growth in accounts that pay for the robotic system through multi-year, minimum volume commitments of incremental implant purchases. At NASS, MDT introduced the Mazor X Stealth, which integrates the Mazor robot with the Company’s StealthStation S8 navigation system. MDT submitted the 510(k) for Mazor X Stealth in July 2018 and the product launch is slated for year-end...

SmartTRAK is excited to be attending SAWC Fall 2018 on November 2-4 at Caesars Palace in Las Vegas.

Susan Paquette, VP & GM Wound, BioMedGPS and Geoffrey Brown, Director Corporate Accounts, Wound Care will be there representing SmartTRAK. Please contact us if you would like to meet.